{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:18:01Z","timestamp":1791908281956,"version":"4.3.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,14]]},"DOI":"10.7759\/cureus.62405","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T03:06:07Z","timestamp":1718420767000},"source":"Crossref","is-referenced-by-count":3,"title":["Assessing Liver Fibrosis in Type 2 Diabetes Mellitus Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: The Role of Non-invasive Scoring Systems and Associated Factors"],"prefix":"10.7759","author":[{"given":"Arindam","family":"Naskar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnibho","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupak","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchika D","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasmit","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"IDF Diabetes Atlas","author":"Magliano DJ","year":"2021","unstructured":"Magliano DJ, Boyko EJ,  IDF Diabetes Atlas 10th edition scientific committee. IDF Diabetes Atlas. International Diabetes Federation, Brussels; 2021. http:\/\/IDF Diabetes Atlas 10th edition scientific committee."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_585_17","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes mellitus","volume":"22","author":"Dharmalingam M","year":"2018","unstructured":"Dharmalingam M, Yamasandhi PG. Nonalcoholic fatty liver disease and type 2 diabetes mellitus. Indian J Endocrinol Metab. 2018, 22:421-8. 10.4103\/ijem.IJEM_585_17","journal-title":"Indian J Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2021.11.010","article-title":"Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis","volume":"12","author":"Shalimar","year":"2022","unstructured":"Shalimar, Elhence A, Bansal B, Gupta H, Anand A, Singh TP, Goel A. Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis. J Clin Exp Hepatol. 2022, 12:818-29. 10.1016\/j.jceh.2021.11.010","journal-title":"J Clin Exp Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi ZM","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, et al.. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019, 71:793-801. 10.1016\/j.jhep.2019.06.021","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher G","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021, 18:599-612. 10.1038\/s41575-021-00448-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/20420188221145549","article-title":"MAFLD: a multisystem disease","volume":"14","author":"Pipitone RM","year":"2023","unstructured":"Pipitone RM, Ciccioli C, Infantino G, et al.. MAFLD: a multisystem disease. Ther Adv Endocrinol Metab. 2023, 14:20420188221145549. 10.1177\/20420188221145549","journal-title":"Ther Adv Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.deman.2023.100161","article-title":"Prevalence of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients from the Eastern region of India","volume":"12","author":"Sinha A","year":"2023","unstructured":"Sinha A, Bankura B. Prevalence of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients from the Eastern region of India. Diabetes Epidemiology and Management. 2023, 12:100161. 10.1016\/j.deman.2023.100161","journal-title":"Diabetes Epidemiology and Management"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.12659\/msm.883601","article-title":"The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease","volume":"18","author":"Cicho\u017c-Lach H","year":"2012","unstructured":"Cicho\u017c-Lach H, Celi\u0144ski K, Prozorow-Kr\u00f3l B, Swatek J, S\u0142omka M, Lach T. The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease. Med Sci Monit. 2012, 18:CR735-40. 10.12659\/msm.883601","journal-title":"Med Sci Monit"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-022-02290-1","article-title":"Distribution of FIB-4 index in the general population: analysis of 75,666 residents who underwent health checkups","volume":"22","author":"Sugiyama A","year":"2022","unstructured":"Sugiyama A, Kurisu A, E B, et al.. Distribution of FIB-4 index in the general population: analysis of 75,666 residents who underwent health checkups. BMC Gastroenterol. 2022, 22:241. 10.1186\/s12876-022-02290-1","journal-title":"BMC Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-021-02038-3","article-title":"FIB-4, APRI, and AST\/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran","volume":"21","author":"Amernia B","year":"2021","unstructured":"Amernia B, Moosavy SH, Banookh F, Zoghi G. FIB-4, APRI, and AST\/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran. BMC Gastroenterol. 2021, 21:453. 10.1186\/s12876-021-02038-3","journal-title":"BMC Gastroenterol"},{"key":"ref11","article-title":"Nonalcoholic Fatty Liver","author":"Kudaravalli P","year":"2023","unstructured":"Kudaravalli P, John S. Nonalcoholic Fatty Liver. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2023.101432","article-title":"Concise review of lipidomics in nonalcoholic fatty liver disease","volume":"49","author":"B\u00e9land-Bonenfant S","year":"2023","unstructured":"B\u00e9land-Bonenfant S, Rouland A, Petit JM, Verg\u00e8s B. Concise review of lipidomics in nonalcoholic fatty liver disease. Diabetes Metab. 2023, 49:101432. 10.1016\/j.diabet.2023.101432","journal-title":"Diabetes Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2010.04.005","article-title":"Relationship between white blood cell count and nonalcoholic fatty liver disease","volume":"42","author":"Lee YJ","year":"2010","unstructured":"Lee YJ, Lee HR, Shim JY, Moon BS, Lee JH, Kim JK. Relationship between white blood cell count and nonalcoholic fatty liver disease. Dig Liver Dis. 2010, 42:888-94. 10.1016\/j.dld.2010.04.005","journal-title":"Dig Liver Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010342","article-title":"Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study","volume":"6","author":"Wang S","year":"2016","unstructured":"Wang S, Zhang C, Zhang G, et al.. Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study. BMJ Open. 2016, 6:e010342. 10.1136\/bmjopen-2015-010342","journal-title":"BMJ Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/262200-assessing-liver-fibrosis-in-type-2-diabetes-mellitus-patients-with-metabolic-dysfunction-associated-steatotic-liver-disease-the-role-of-non-invasive-scoring-systems-and-associated-factors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T03:06:14Z","timestamp":1718420774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/262200-assessing-liver-fibrosis-in-type-2-diabetes-mellitus-patients-with-metabolic-dysfunction-associated-steatotic-liver-disease-the-role-of-non-invasive-scoring-systems-and-associated-factors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.62405","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,14]]}}}